Maryland Capital Management Dexcom Inc Transaction History

Maryland Capital Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$67.99 - $132.89 $35,694 - $69,767	-525 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$94.08 - $130.2 $1,881 - $2,604	20 Added 3.96%	525 $269,000
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $20,129 - $25,237	-155 Reduced 23.48%	505 $271,000
Q4 2020 Feb 11, 2021	SELL	$78.0 - $104.5 $780 - $1,045	-10 Reduced 1.49%	660 $244,000
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $955 - $1,129	10 Added 1.52%	670 $276,000

Q2 2020 Aug 12, 2020	SELL	$62.68 - $105.34 $16,610 - $27,915	-265 Reduced 28.65%	660 $268,000
Q1 2020 May 13, 2020	BUY	$47.79 - $75.63 $44,205 - $69,957	925 New	925 $249,000

1,124

353M

4.19M

4.54M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $43.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

Stay updated on Maryland Capital Management with notifications on news.